or
Bookmark and Share
Pyrrolo[1,2-a]imidazoles and imidazo[1,2-a]pyridines
   
Document Number
US Patent 4507481
Issued Date
March 26, 1985
Link
Inventors
Map
Abstract
Novel 7-ether and 7-thioether derivatives of 2-aryl, 3-aryl, and 2,3-diaryl-2,5,6,7-tetrahydro-3H-pyrrolo[1,2-a]-imidazole and 8-ether and 8-thioether derivatives of 2-aryl, 3-aryl, and 2,3-diaryl-2,3,5,6,7,8-hexahydro-imidazo[1,2-a]-pyridine, such as 2,3,5,6,7,8-hexahydro-2-phenyl-8,8-dimethoxy-imidazo[1,2-a]pyridine hydrochloride, useful as immunomodulators.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
4
Comments:
no comments yet
Owner
Pennwalt Corporation (Philadelphia, PA)
Published
March 26, 1985
Application Number
06/518,514
Filed
July 29, 1983
US Classification
546/121   548/302.7
Int'l Classification
C07D   471/00   (20060101)   C07D   471/04   (20060101)   C07D   487/04   (20060101)   C07D   487/00   (20060101)  
Examiner
Assistant Examiner
USPTO Field of Search
546/121   548/324  
Related Patents
4551535 - Process for preparing novel 7-thioester derivatives of 3H pyrrolo [1,2-a]-imidazole and 8-thioester derivatives of imidazo [1,2-a] pyridine - Owned by Pennwalt Corporation (Philadelphia, PA)

The instantly claimed invention is a process for preparing novel 7-thioether derivatives of 2-aryl, 3 aryl, and 2,3-diary-2,5,7,7-tetra-hydro-3H-pyrrolo [1,2-a] imidazole and 8-thio-ether derivatives of 2-aryl, 3-aryl, and 2,3-diaryl-2,3,5,7,7,8-hexahydro-imidazo [1,2-a]-pyridine which comprises (a) contacting the corresponding amidine with about one molar equivalent of R.sub.1 SSR.sub.1 in the presence of about two molar equivalents of base and at a temperature of -78.degree. C. to about 0.degree. C. (b) contacting the corresponding amidine compound with about two molar equivalents of R,SSR, in the presence of about two molar equivalents of a base and at a temperature of from about -78.degree. C. to about 23.degree. C., said compounds being useful as immunomodulators.

4728645 - Substituted imidazo[1,5-A]pyridine derivatives and other substituted bicyclic derivatives, useful as aromatase inhibitors - Owned by Ciba-Geigy Corporation (Ardsley, NY)

Disclosed are compounds of formula I ##STR1## wherein R.sub.1 represents hydrogen, lower alkyl, substituted lower alkyl, nitro, halogen, free, etherified or esterified hydroxy, free, etherified, oxidized etherified or esterified mercapto, unsubstituted, mono- or disubstituted amino, ammonio, free or functionally modified sulfo, free or functionally modified formyl, C.sub.2 -C.sub.20 -acyl, cyano, free or functionally modified carboxy; and R.sub.2 represents hydrogen, lower alkyl, substituted lower alkyl, halogen; free, etherified or esterified hydroxy; free, etherified, oxidized etherified or esterified mercapto; free or functionally modified carboxy, or acyl; the 7,8-dihydro derivatives thereof; and compounds of the formula I* ##STR2## wherein n denotes 0, 1, 2, 3 or 4, and R.sub.1 and R.sub.2 are as defined above under formula I and salts thereof; e.g. as aromatase inhibitors; pharmaceutical compositions containing these compounds; the use of these compounds for the treatment of conditions responsive to e.g. aromatase inhibition in mammals; processes and intermediates for preparing these compounds.

5498774 - Condensed heterocyclic compounds, their production and use - Owned by Takeda Chemical Industries, Ltd. (Osaka,JP)

A condensed heterocyclic compound of the general formula: ##STR1## wherein Q is a condensed heterocyclic group having a nitrogen atom in the bridgehead which is unsubstituted or substituted, X is a hydrogen atom or a group attached through C, O, S or N, and Y is an electron attractive group, or its salt which is useful as agricultural chemical.

4794114 - Inhibition of interleukin-1 production by monocytes and/or macrophages - Owned by SmithKline Beckman Corporation (Philadelphia, PA)

A method of inhibiting the 5-lipoxygenase pathway in an animal in need thereof which comprises administering an effective, 5-lipoxygenase pathway inhibiting amount of a diaryl-substituted imidazole fused to a thiazole pyrrolidine, thiazide or piperidine ring to such animal.

4670445 - Inotropic agents - Owned by Eli Lilly and Company (Indianapolis, IN)

This invention provides for certain phenyl-substituted imidazo compounds, their pharmaceutical formulations, and their use as positive inotropic agents and vasodilators.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us